What changed today in Regulatory: 1 recall record
Every new official record on the Pharmacy, Compounding & Regulatory Intelligence desk since this morning, each linked to its primary source.
The signal
NPHLA tracked 1 new official record on this desk today: 1 recall record.
Why this matters
Federal Register documents and FDA notices can change compliance obligations, deadlines and enforcement priorities for pharmacies, compounders and prescribers.
What changed
- Recall: Family Farmstead Dairy Announces Recall of Raw Mild Cheddar Cheese Due to Potential E. coli O26:H11 and O45:H2 Contamination — reason given: not stated (firm: not stated).[1]
- Also reported by Endpoints News: “FDA considers interim access for compounded peptides; Enspryng's label expansion”.[2]
- Also reported by American Med Spa Association: “FDA Sends Peptide ‘Interim Access Policy’ to White House for Review”.[3]
- Also reported by STAT: “STAT+: Pharmalittle: We’re reading about an HHS peptide push, Trump’s pharma stock holdings, and more”.[4]
Who this affects
- Pharmacies
- 503A compounders
- 503B outsourcing facilities
- Pharmacists
- Prescribers
- Practice owners & operators
What to watch next
No new verified deadlines in today’s records. See Deadline Watch for upcoming dates.
NPHLA takeaway
These are factual summaries of official records with no interpretation. Open the primary documents for full details; NPHLA editors add analysis where developments warrant it.
Source file
- [1]
- [2]
- [3]
- [4]
Compiled automatically from primary official sources and peer-reviewed literature. Each line is a factual summary of a public record, linked to it — no interpretation is added. NPHLA links to sources and does not republish their text. Professional information only — not medical, legal or regulatory advice for any individual situation. Our standards.